Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Point of Care Diagnostics/Testing Market, by End User
8.1 Hospitals & Clinics
8.2 Diagnostic Centers
8.3 Homecare/Self Testing
8.4 Others
9. Point of Care Diagnostics/Testing Market, by Mode of Purchase
9.1 OTC Testing Products
9.2 Prescription-based testing products
10. Point of Care Diagnostics/Testing Market, by Platform
10.1 Immunoassays
10.2 Molecular Diagnostics
10.3 Dipsticks
10.4 Others
11. Point of Care Diagnostics/Testing Market, by Product
11.1 Glucose Monitoring
11.2 Cardiometabolic Monitoring
11.3 Infectious Disease Testing
11.4 Coagulation Monitoring
11.5 Pregnancy & Fertility Testing
11.6 Hematology Testing
11.7 Cancer/Tumor Marker Testing
11.8 Urinalysis Testing
11.9 Cholesterol
11.10 Drugs-of-Abuse Testing
11.11 Others
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 USA
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 France
12.3.4 Italy
12.3.5 Spain
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4 Asia-Pacific
12.4.1 Japan
12.4.2 South Korea
12.4.3 China
12.4.4 India
12.4.5 Australia
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.1 Israel
12.5.2 UAE
12.5.3 South Africa
12.5.4 Rest
12.6 Latin America
12.6.1 Brazil
12.6.2 Argentina
12.6.3 Rest of Latin America
13. Company Profiles
13.1 Hoffmann-La Roche Ltd
13.1.1 Financial
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 Johnson & Johnson Services, Inc.
13.3 PTS Diagnostics
13.4 Nova Biomedical
13.5 QuidelCorporation
13.6 Abbott Laboratories
13.7 Siemens Healthineers GmbH
13.8 Chembio Diagnostics, Inc.
13.9 Becton, Dickinson, and Company
13.10 Danaher Corporation
14. Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share Analysis
14.3 Recent Developments
15. Conclusion
Frequently Asked Questions
Ans: The challenge that manufacturers face is deploying their products in accordance with regional authorities.
-
Globally, the number of chronic disease cases is increasing.
-
There is an increasing demand for AI-integrated proofs-of-concept for real-time diagnostics.
Ans: Point of care diagnostics/testing is a type of health analysis that is performed near the patient and does not require a laboratory environment. Point of care (POC) testing is also known as near-patient testing, bedside testing, mobile testing, remote testing, and rapid diagnosis.
Ans: The Point of Care Diagnostics/Testing market is to grow at a CAGR of 11.9% over the forecast period 2023-2030.
Ans: The Point of Care Diagnostics/Testing Market Size was valued at USD 23.99 billion in 2022.
Get in touch
